ERβ targets ZAK and attenuates cellular hypertrophy via SUMO‐1 modification in H9c2 cells-Reference-Cited by-同舟云学术

ERβ targets ZAK and attenuates cellular hypertrophy via SUMO‐1 modification in H9c2 cells

Published:2018-06-22 Issue:9 Volume:119 Page:7855-7864
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Pai Peiying¹,Shibu Marthandam Asokan²,Chang Ruey‐Lin³,Yang Jaw‐Ji⁴,Su Chia‐chi²,Lai Chao‐Hung⁵,Liao Hung‐En⁶,Viswanadha Vijaya Padma⁷,Kuo Wei‐Wen⁸,Huang Chih‐Yang²⁹¹⁰^ORCID

Affiliation:

1. Division of Cardiology China Medical University Hospital Taichung Taiwan

2. Graduate Institute of Basic Medical Science China Medical University Taichung Taiwan

3. College of Chinese Medicine, School of Post‐Baccalaureate Chinese Medicine China Medical University Taichung Taiwan

4. Institute of Medicine, School of Dentistry Chung‐Shan Medical University Taichung Taiwan

5. Division of Cardiology, Department of Internal Medicine Taichung Armed Force General Hospital Taichung Taiwan

6. Department of Healthcare Administration Asia University Taichung Taiwan

7. Department of Biotechnology Bharathiar University Coimbatore India

8. Department of Biological Science and Technology China Medical University Taichung Taiwan

9. Department of Biotechnology Asia University Taichung Taiwan

10. Graduate Institute of Chinese Medical Science China Medical University Taichung Taiwan

Funder

Ministry of Health and Welfare

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.27199

Reference48 articles.

1. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

2. Coronary Heart Disease: Reducing the Risk

3. Androgens and Coronary Artery Disease

4. Cardiac myocytes and fibroblasts contain functional estrogen receptors 1

5. The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe Part 1: patient characteristics and diagnosis

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent discoveries of the role of histone modifications and related inhibitors in pathological cardiac hypertrophy;Drug Discovery Today;2024-02

2. SUMOylation targeting mitophagy in cardiovascular diseases;Journal of Molecular Medicine;2022-09-26

3. SUMO2-mediated SUMOylation of SH3GLB1 promotes ionizing radiation-induced hypertrophic cardiomyopathy through mitophagy activation;European Journal of Pharmacology;2022-06

4. hucMSC-Derived Exosomes Alleviate the Deterioration of Colitis via the miR-146a/SUMO1 Axis;Molecular Pharmaceutics;2022-01-27

5. Cardioprotective Effect of Spinosin against Doxorubicin Induced Inflammatory and Hypertrophy via Nrf2 Signaling;Pakistan Journal of Zoology;2022